Title: Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays
Xiaofang Bian
Special MTA: None
ATGTCGTCGCGGCGTCGCAGCTCGTCACGTCGCTCTGGCGAACCCTCGACGGTGATTTAT
ATCCCCTCGAGCAACGAGGACACACCGGCGGATGAGGAGGCGGAGGACAGCGTTTTCACG
AGCACGCGGGCGCGCAGCGCCACGGAAGATCTGGATCGCATGGAGGCCGGTTTGTCGCCC
TACAGCGTCTCCTCGGACGCTCCGTCGTCCTTCGAGCTCGTGCGCGAGACCGGCGGCACC
GGCGCCGCCAAGAAACCGAGCGAAAAGAAACGATCGTCGTCGCGTCGGCAACCGCAGATC
GCAGCGGGCGCGCCTCGGGGCTCGCCGGCGACACCCAAGGCCGGCAAGTCGCCTAAAGTC
TCGCGACCGCCTAGTGTGCCCTCGCTGCCCGAGAACGGTGCCGGCGGCGGTGGCGACGAT
AACAGCAGCAGCGGCGGTAGCAGCAGTCGCACCACCAGTAACAGTAGCAGAAGCACCAGT
CCCGTGGCGCCAGGTGAGCCGTCCGCTGCCGAGGGCGATGAGTTTTCCTTCTGCGACAGC
GACATCGAAGACTTTGAGCGCGAATGTTACCGGGTCAGCGTGGCCGACAATCTGGGCTTC
GAGCCCAGCGTGGTCGCGCCGCAGCACGTCGAGTATCTCAAATTCGTGCTGCAAGACTTT
GACGTGCAGCACCTCCGCCGCCTCAACGAATGCATACCCATGCCGGCCTTTGCGCTCACC
AGCCTCGTCGACCCCGTCTTAAACAACGTAGCGCCTGGCGAGCGCGATCTCACGCGTCGG
ATAATCACGCACGCGGTGATCATCAACTATTACTACGTGGCGCAAAAGAAAGCGCGCCAC
ATGGTGGAGGCCATACGGACCACCGTGCGGGGCGACACGGTACGCCGGGTAGCCGCGCAG
GTCAACAACCAGAGCCGTTCGGGGCGTGCGGCCGCGCTAGCGCTTCACTTTCTCACGTCA
CGAAAAGGAGTGACGGACGGCCAGTACGCCACGTCTCTGCGGCGGCTGGACGAAGAGCTG
CGGCATCGCGGCACGCCCGAATCGCCGCGGCTCACCGAGGTCTACCAGACGCTACGCGAT
TACAACGTGCTCTTCTATACCGCCCACTACACCTCGCGCGGCGCGCTCTACCTCTATCGG
CAAAACCTGCAGCGGCTCAACGAGAACCACCGGGGCATGCTCCGGCTGCTTTCGGTCGAA
GAGATATGCGAAGAGCACACGCTCAACGATCTGGCGTTCCTAGTAGGCGTCGAGCTTATG
ATCACGCACTTTCAACGCACCATTCGCGTACTGCGCTGCTATCTCCAGCACCAGCTGCAG
AGCATCTCGGAGCTGTGTTACCTCATCTATGTACAACTGCCGTCGCTGCGCGAAGACTAC
GCGCAGCTTAGTGACGTGCTCTACTGGGCCGTTAGTCAAAACTACGACTACGCGCTCTAC
GCGAGCACGCCGGCGTTGTTTGACTTTTTACGCGTCGTGCGTCAGCAGGACGCCTTCATT
TGCACCGACTACGTGTACTGCGCCCTGCGCCTGCTGGCCTGTCCCGACAGACCTATTATC
GGTGACACCGGCGGCAGCAATAGCTCCCAACGCCTCGTAGGCGAGTTTATGGTGCGCGAT
CCGCTGTTGCGCGACCCGCGCGCCACCCACCTGCGCCAGAAACTCATCACCCGCGACATA
TGCGTGGCGCGGTTGCAAGCGCAGCCCTCGAGTCGACACATTCCGGTCGAACACACGGGT
GTCTCCTCCGTCACCCTGCTCAAAATCTTTAGCCAGGTCCCCCCCGACGAACGCGAAGAA
GACACGTTACGCGAGATGGCTCTTAAAGCGTTTATGGAAGCGAACGGTAATCACCCCGAA
CAAATCTGCCGATCCCCACCACCCCCGCTGCCGCCGCGCGACTATCCTCAACGCGACGAG
CGGGACCGTCACCGTCGCGACCGCCGCGACAGCGGGGAGTACTGTTGC
MSSRRRSSSRRSGEPSTVIYIPSSNEDTPADEEAEDSVFTSTRARSATEDLDRMEAGLSP YSVSSDAPSSFELVRETGGTGAAKKPSEKKRSSSRRQPQIAAGAPRGSPATPKAGKSPKV SRPPSVPSLPENGAGGGGDDNSSSGGSSSRTTSNSSRSTSPVAPGEPSAAEGDEFSFCDS DIEDFERECYRVSVADNLGFEPSVVAPQHVEYLKFVLQDFDVQHLRRLNECIPMPAFALT SLVDPVLNNVAPGERDLTRRIITHAVIINYYYVAQKKARHMVEAIRTTVRGDTVRRVAAQ VNNQSRSGRAAALALHFLTSRKGVTDGQYATSLRRLDEELRHRGTPESPRLTEVYQTLRD YNVLFYTAHYTSRGALYLYRQNLQRLNENHRGMLRLLSVEEICEEHTLNDLAFLVGVELM ITHFQRTIRVLRCYLQHQLQSISELCYLIYVQLPSLREDYAQLSDVLYWAVSQNYDYALY ASTPALFDFLRVVRQQDAFICTDYVYCALRLLACPDRPIIGDTGGSNSSQRLVGEFMVRD PLLRDPRATHLRQKLITRDICVARLQAQPSSRHIPVEHTGVSSVTLLKIFSQVPPDEREE DTLREMALKAFMEANGNHPEQICRSPPPPLPPRDYPQRDERDRHRRDRRDSGEYCC
Coding Sequence Details
Recommended Growth Condition: